Long term continuous hepatic artery infusion of FUDR was carried out in 34 rats. In the animals who received a constant infusion schedule of 15mg/kg/day all died of toxicity with a mean survival of 9.3 days. If the pattern of the continuous infusion was changed so that over 60% of the infusion was given during the hours of 3pm to 9pm then all of the animals survived the 14 day infusion. If the maximum dose of infusion was changed so that 60% of the infusion was given at night from 3am to 9am the infusion became more toxic and all the animals died in a mean of 5.5 days. Pathologic sectioning of al! the livers reflected the above outcomes with the greatest amount of hepatic necrosis in the animals on the night cycles. This study underscores the recent advances in chronobiology demonstrating that for continuous hepatic arterial infusions the timing of delivery is crucial in determining the toxicity.
INTRODUCTION
Continuous hepatic artery infusion of FUDR has been studied in patients with colorectal metastases to the liver for the past 10 years. It is still the therapy that has the best response rates in these clinical situations, but many clinicians fear its use because of the severe and often fatal biliary toxicities associated with this treatment. Specifically biliary sclerosis, sometimes referred to as sclerosing cholangitis, can result after continuous hepatic artery infusion(CHAI) of floxuridine(FUDR) 1.
Although the complication is dose related, some patients develop biliary sclerosis even at the lowest dose of 0.1 mg/kg/d. Clearly a method to reduce this toxicity would enhance the usefulness of CHAI of FUDR. There has been a suggestion that using a circadian rhythm for the CHAI can lower the toxicity. Previous experiments were done in rats using an intravenous approach which did show a decrease of the toxicity of infusion for rats given a circadian pattern with the greatest amount given during the afternoon hours2. The present study utilizes a rat model which is identical to the human CHAI model. The rats all have hepatic artery catheters through which continuous infusions can be performed for 14 days, which is the same amount of time as the human perfusions. Using this model we studied the effects that changing flow rates of the FUDR had on the toxicity to the liver parenchyma. Eleven rats were placed on a constant infusion cycle of FUDR (Roche) at 15 mg/ kg/day. The infusion was started 24 hours after the operation for placement of the catheter. Eleven rats were placed on a "day" cycle of infusion. In these animals a total dose of 15 mg/kg/day of FUDR was given in a volume of 4 cc/day. The infusion schedule was as follows: From 9am to 3pm 0.6cc was infused(0.1cc/hr), from 3pm to 9pm 2.7cc(0.45cc/hr) was infused, from 9pm to 3am 0.6cc(0.1cc/hr) was infused and from 3am to 9am 0.08cc(.013cc/hr) was infused (see Table 1 ).
MATERIAL AND METHOD
Twelve rats received 15 mg/kg/day of FUDR on a "night" cycle again in a volume of 4cc/d. These animals received 0.6cc from 9am to 3pm, 0.08cc from 3pm to 9pm, 2.7cc from 9pm to 3am and 0.6cc from 3am to 9am (see Table 2 ). All the infusions were given for 14 consecutive days or until the animal died if less than 14 days. The animals that survived the 14 day FUDR infusion were then infused with heparin and saline for 14 more days at which time they were sacrificed.
The livers of all the animals were excised and fixed in 10% neutral buffered formalin prior to pathological examination. All livers were sectioned at 3 mm intervals with no less than 2 blocks submitted for paraffin sections, which included any grossly visible lesion as well as representative hepatic parenchyma. A minimum of 4 cm 2 crosssectional area was examined histologically in each case. Hematoxylin and Eosin (H&E) stained sections were examined by two independent pathologists utilizing conventional light microscopy.
RESULTS
All of the 11 animals on the constant infusion of FUDR died in 6 to 12 days with a mean survival of 9.3 days + 1.7 (Table 3) . Seven of these animals were Fisher rats There was no statistically significant difference between the survival in these two strains.. The group with the day cycle had the best response since none of the rats died of toxicity during the infusion. There was a statistically significant difference in the survival of the animals on the night cycle versus the constant infusion (Paired t-test p < .0001). The group treated with the night cycle had a poorer survival.
PATHOLOGY
The livers from rats who had received a constant continuous infusion of FUDR were noted to contain rare portal chronic inflammatory cells and minimal centrilobular congestion as well as small degenerative foci within lobules. The general architecture appeared preserved with foci of single hepatocyte necrosis, swelling and vacuolization. Multifocal microvacuolar fatty changes were noted, predominantly in the centrilobular areas (Figure 1 ). For rats who had received a circadian timed day infusion of FUDR their livers had rare foci of hepatocyte swelling (Figure 2 ). The livers in the rats who received a timed infusion of FUDR with the majority of the drug given at night had multifocal broad areas of necrosis some of which were extensive without identifiable zonal predilection. There was also extensive vacuolar degeneration with macrovacuolar fatty change predominantly in centrilobular areas. There was marked centrilobular chronic passive congestion. No significant lobular or portal inflammatory response was noted. A mild, diffuse, Kupffer cell hyperplasia was identified in those cases with extensive necrosis (Figure 3 ). at a constant rate had varying plasma concentrations of the drug depending on the time of day. The lowest concentrations were seen during the daylight hours and the highest were at 12 midnight. There was a definite circadian pattern to the concentrations suggesting more absorption and metabolism during the day. Since the liver was the main organ of clearance of 5-FU this finding suggested a circadian pattern to hepatic metabolism9.
When these concepts were utilized in patterning chemotherapy infusions new information on toxicity was obtained. A study of a continuous intravenous infusion of FUDR given to rats with a maximal daytime dose and minimal night dose was found to be less toxic than on a constant continuous infusion2.
Toxicity is of key importance in the clinical setting when continuous hepatic artery infusion of FUDR is used for hepatic metastases. Implantable pumps have been used for over 10 years to get response rates of over 50% in patients with hepatic metastases from colorectal cancer1 '11. No other modality at this time produces comparable responses in hepatic metastases. The main reason that hepatic infusion has not been universally adopted as the treatment of choice for colorectal metastases to the liver is because of the incidence of biliary sclerosis associated with therapy. 
